US FDA Restarting Domestic Inspections, Prioritizing Areas With Low Covid-19 Rates

The agency is resuming domestic inspections using a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.